The Biden-Harris administration announced a program of hundreds of “one-stop Test to Treat” locations where people can test for COVID-19 and receive immediate prescriptions and distribution of oral antiviral medication for free. Individuals can continue to test and get treatment from their healthcare providers who can prescribe these medications at locations where they are being distributed.
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for Paxlovid for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients over 12. Paxlovid is covered for TRICARE beneficiaries if ordered by a provider.
Get clinical resources for COVID-19 vaccination, including distribution and administration, the storage and handling of, reporting and education for each separate vaccine.
Starting January 15, 2022, private health insurers must cover the cost of eight at-home COVID-19 tests per month. However, this policy will not apply to TRICARE. Beneficiaries must still have a prescription indicating a medical necessity for the test for the beneficiary to be reimbursed. If a beneficiary buys an at-home test without a prescription, TRICARE will not cover it.